In conclusion, piperazine-derived compound HJZ-12 suppressed BPH progress and induced apoptosis through deregulation of signal transduction pathways, potentially involving Bmi-1 signaling. The gene discussed is BMI1; the disease is benign prostatic hyperplasia.